Download Zipped Introduced WP 8.0 HB0077S1.ZIP 32,297 Bytes
[Status][Bill Documents][Fiscal Note][Bills Directory]

First Substitute H.B. 77

Representative Ron Bigelow proposes to substitute the following bill:


             1     
CONTROLLED SUBSTANCES AMENDMENTS

             2     
2000 GENERAL SESSION

             3     
STATE OF UTAH

             4     
Sponsor: Ron Bigelow

             5      AN ACT RELATING TO CRIMINAL LAW AND CONTROLLED SUBSTANCES;
             6      AMENDING THE SCHEDULE OF CONTROLLED SUBSTANCES TO INCLUDE GHB;
             7      SCHEDULING KETAMINE; CHANGING THE SCHEDULE OF ROHYPNOL; AND
             8      INCLUDING ANALOGS.
             9      This act affects sections of Utah Code Annotated 1953 as follows:
             10      AMENDS:
             11          58-37-4, as last amended by Chapter 283, Laws of Utah 1998
             12          58-37c-3, as last amended by Chapter 100, Laws of Utah 1998
             13          58-37c-8, as last amended by Chapter 100, Laws of Utah 1998
             14      ENACTS:
             15          58-37-5.5, Utah Code Annotated 1953
             16      Be it enacted by the Legislature of the state of Utah:
             17          Section 1. Section 58-37-4 is amended to read:
             18           58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
             19      required -- Specific substances included in schedules.
             20          (1) There are established five schedules of controlled substances known as Schedules I,
             21      II, III, IV, and V which shall consist of substances listed in this section.
             22          (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by the
             23      official name, common or usual name, chemical name, or brand name designated:
             24          (a) Schedule I:
             25          (i) Unless specifically excepted or unless listed in another schedule, any of the following


             26      opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when
             27      the existence of the isomers, esters, ethers, and salts is possible within the specific chemical
             28      designation:
             29          (A) Acetyl-alpha-methylfentanyl
             30      (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
             31          (B) Acetylmethadol;
             32          (C) Allylprodine;
             33          (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
             34      levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
             35          (E) Alphameprodine;
             36          (F) Alphamethadol;
             37          (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
             38      propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine);
             39          (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
             40      piperidinyl]-N-phenylpropanamide);
             41          (I) Benzethidine;
             42          (J) Betacetylmethadol;
             43          (K) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
             44      piperidinyl]-N-phenylpropanamide);
             45          (L) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
             46      phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
             47          (M) Betameprodine;
             48          (N) Betamethadol;
             49          (O) Betaprodine;
             50          (P) Clonitazene;
             51          (Q) Dextromoramide;
             52          (R) Diampromide;
             53          (S) Diethylthiambutene;
             54          (T) Difenoxin;
             55          (U) Dimenoxadol;
             56          (V) Dimepheptanol;


             57          (W) Dimethylthiambutene;
             58          (X) Dioxaphetyl butyrate;
             59          (Y) Dipipanone;
             60          (Z) Ethylmethylthiambutene;
             61          (AA) Etonitazene;
             62          (BB) Etoxeridine;
             63          (CC) Furethidine;
             64          (DD) Hydroxypethidine;
             65          (EE) Ketobemidone;
             66          (FF) Levomoramide;
             67          (GG) Levophenacylmorphan;
             68          (HH) Morpheridine;
             69          (II) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
             70          (JJ) Noracymethadol;
             71          (KK) Norlevorphanol;
             72          (LL) Normethadone;
             73          (MM) Norpipanone;
             74          (NN) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
             75      propanamide;
             76          (OO) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
             77          (PP) Phenadoxone;
             78          (QQ) Phenampromide;
             79          (RR) Phenomorphan;
             80          (SS) Phenoperidine;
             81          (TT) Piritramide;
             82          (UU) Proheptazine;
             83          (VV) Properidine;
             84          (WW) Propiram;
             85          (XX) Racemoramide;
             86          (YY) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
             87          (ZZ) Tilidine;


             88          (AAA) Trimeperidine;
             89          (BBB) 3-methylfentanyl, including the optical and geometric isomers
             90      (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
             91          (CCC) 3-methylthiofentanyl
             92      (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
             93          (ii) Unless specifically excepted or unless listed in another schedule, any of the following
             94      opium derivatives, their salts, isomers, and salts of isomers when the existence of the salts,
             95      isomers, and salts of isomers is possible within the specific chemical designation:
             96          (A) Acetorphine;
             97          (B) Acetyldihydrocodeine;
             98          (C) Benzylmorphine;
             99          (D) Codeine methylbromide;
             100          (E) Codeine-N-Oxide;
             101          (F) Cyprenorphine;
             102          (G) Desomorphine;
             103          (H) Dihydromorphine;
             104          (I) Drotebanol;
             105          (J) Etorphine (except hydrochloride salt);
             106          (K) Heroin;
             107          (L) Hydromorphinol;
             108          (M) Methyldesorphine;
             109          (N) Methylhydromorphine;
             110          (O) Morphine methylbromide;
             111          (P) Morphine methylsulfonate;
             112          (Q) Morphine-N-Oxide;
             113          (R) Myrophine;
             114          (S) Nicocodeine;
             115          (T) Nicomorphine;
             116          (U) Normorphine;
             117          (V) Pholcodine; and
             118          (W) Thebacon.


             119          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             120      compound, mixture, or preparation which contains any quantity of the following hallucinogenic
             121      substances, or which contains any of their salts, isomers, and salts of isomers when the existence
             122      of the salts, isomers, and salts of isomers is possible within the specific chemical designation; as
             123      used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and geometric isomers:
             124          (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
             125      .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
             126          (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
             127      4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
             128          (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
             129      2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
             130          (D) 2,5-dimethoxyamphetamine, some trade or other names:
             131      2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
             132          (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
             133          (F) 4-methoxyamphetamine, some trade or other names:
             134      4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
             135          (G) 5-methoxy-3,4-methylenedioxyamphetamine;
             136          (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
             137      4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
             138          (I) 3,4-methylenedioxy amphetamine;
             139          (J) 3,4-methylenedioxymethamphetamine (MDMA);
             140          (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
             141      alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
             142          (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
             143      N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
             144          (M) 3,4,5-trimethoxy amphetamine;
             145          (N) Bufotenine, some trade and other names: 3-(. -Dimethylaminoethyl)-5-hydroxyindole;
             146      3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine;
             147      mappine;
             148          (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
             149          (P) Dimethyltryptamine, some trade or other names: DMT;


             150          (Q) Ibogaine, some trade and other names:
             151      7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
             152      [5,4-b] indole; Tabernanthe iboga;
             153          (R) Lysergic acid diethylamide;
             154          (S) Marijuana;
             155          (T) Mescaline;
             156          (U) Parahexyl, some trade or other names:
             157      3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
             158          (V) Peyote, meaning all parts of the plant presently classified botanically as Lophophora
             159      williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such
             160      plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant,
             161      its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
             162          (W) N-ethyl-3-piperidyl benzilate;
             163          (X) N-methyl-3-piperidyl benzilate;
             164          (Y) Psilocybin;
             165          (Z) Psilocyn;
             166          (AA) Tetrahydrocannabinols, synthetic equivalents of the substances contained in the
             167      plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and
             168      their isomers with similar chemical structure and pharmacological activity such as the following:
             169      .1 cis or trans tetrahydrocannabinol, and their optical isomers .6 cis or trans
             170      tetrahydrocannabinol, and their optical isomers .3,4 cis or trans tetrahydrocannabinol, and its
             171      optical isomers, and since nomenclature of these substances is not internationally standardized,
             172      compounds of these structures, regardless of numerical designation of atomic positions covered;
             173          (BB) Ethylamine analog of phencyclidine, some trade or other names:
             174      N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
             175      N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
             176          (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
             177      1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
             178          (DD) Thiophene analog of phencyclidine, some trade or other names:
             179      1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
             180          (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.


             181          (iv) Unless specifically excepted or unless listed in another schedule, any material
             182      compound, mixture, or preparation which contains any quantity of the following substances having
             183      a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers
             184      when the existence of the salts, isomers, and salts of isomers is possible within the specific
             185      chemical designation:
             186          (A) Mecloqualone; and
             187          (B) Methaqualone.
             188          (v) Any material, compound, mixture, or preparation containing any quantity of the
             189      following substances having a stimulant effect on the central nervous system, including their salts,
             190      isomers, and salts of isomers:
             191          (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
             192      4,5-dihydro-5-phenyl-2-oxazolamine;
             193          (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
             194      alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
             195          (C) Fenethylline;
             196          (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
             197      alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
             198      alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
             199      methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
             200      optical isomers;
             201          (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
             202          (F) N-ethylamphetamine; and
             203          (G) N,N-dimethylamphetamine, also known as N,N-alpha-trimethyl-benzeneethanamine;
             204      N,N-alpha-trimethylphenethylamine.
             205          (vi) Any material, compound, mixture, or preparation which contains any quantity of the
             206      following substances, including their optical isomers, salts, and salts of isomers, subject to
             207      temporary emergency scheduling:
             208          (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
             209          (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
             210          (vii) Unless specifically excepted or unless listed in another schedule, any material,
             211      compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate


             212      (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.
             213          (b) Schedule II:
             214          (i) Unless specifically excepted or unless listed in another schedule, any of the following
             215      substances whether produced directly or indirectly by extraction from substances of vegetable
             216      origin, or independently by means of chemical synthesis, or by a combination of extraction and
             217      chemical synthesis:
             218          (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
             219      opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
             220      and their respective salts, but including:
             221          (I) Raw opium;
             222          (II) Opium extracts;
             223          (III) Opium fluid;
             224          (IV) Powdered opium;
             225          (V) Granulated opium;
             226          (VI) Tincture of opium;
             227          (VII) Codeine;
             228          (VIII) Ethylmorphine;
             229          (IX) Etorphine hydrochloride;
             230          (X) Hydrocodone;
             231          (XI) Hydromorphone;
             232          (XII) Metopon;
             233          (XIII) Morphine;
             234          (XIV) Oxycodone;
             235          (XV) Oxymorphone; and
             236          (XVI) Thebaine;
             237          (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
             238      identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
             239      substances may not include the isoquinoline alkaloids of opium;
             240          (C) Opium poppy and poppy straw;
             241          (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any
             242      salt, compound, derivative, or preparation which is chemically equivalent or identical with any of


             243      these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives, and salts of
             244      isomers and derivatives, whether derived from the coca plant or synthetically produced, except the
             245      substances may not include decocainized coca leaves or extraction of coca leaves, which
             246      extractions do not contain cocaine or ecgonine; and
             247          (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
             248      liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
             249          (ii) Unless specifically excepted or unless listed in another schedule, any of the following
             250      opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, when
             251      the existence of the isomers, esters, ethers, and salts is possible within the specific chemical
             252      designation, except dextrorphan and levopropoxyphene:
             253          (A) Alfentanil;
             254          (B) Alphaprodine;
             255          (C) Anileridine;
             256          (D) Bezitramide;
             257          (E) Bulk dextropropoxyphene (nondosage forms);
             258          (F) Carfentanil;
             259          (G) Dihydrocodeine;
             260          (H) Diphenoxylate;
             261          (I) Fentanyl;
             262          (J) Isomethadone;
             263          (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
             264      levomethadyl acetate, or LAAM;
             265          (L) Levomethorphan;
             266          (M) Levorphanol;
             267          (N) Metazocine;
             268          (O) Methadone;
             269          (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
             270          (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
             271      acid;
             272          (R) Pethidine (meperidine);
             273          (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;


             274          (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
             275          (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
             276          (V) Phenazocine;
             277          (W) Piminodine;
             278          (X) Racemethorphan;
             279          (Y) Racemorphan;
             280          (Z) Remifentanil; and
             281          (AA) Sufentanil.
             282          (iii) Unless specifically excepted or unless listed in another schedule, any material,
             283      compound, mixture, or preparation which contains any quantity of the following substances having
             284      a stimulant effect on the central nervous system:
             285          (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
             286          (B) Methamphetamine, its salts, isomers, and salts of its isomers;
             287          (C) Phenmetrazine and its salts; and
             288          (D) Methylphenidate.
             289          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             290      compound, mixture, or preparation which contains any quantity of the following substances having
             291      a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers
             292      when the existence of the salts, isomers, and salts of isomers is possible within the specific
             293      chemical designation:
             294          (A) Amobarbital;
             295          (B) Flunitrazepam, trade name Rohypnol;
             296          [(B)] (C) Glutethimide;
             297          [(C)] (D) Pentobarbital;
             298          [(D)] (E) Phencyclidine;
             299          [(E)] (F) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
             300      1-piperidinocyclohexanecarbonitrile (PCC); and
             301          [(F)] (G) Secobarbital.
             302          (v) Unless specifically excepted or unless listed in another schedule, any material,
             303      compound, mixture, or preparation which contains any quantity of Phenylacetone.
             304          Some of these substances may be known by trade or other names: phenyl-2-propanone,


             305      P2P; benzyl methyl ketone, methyl benzyl ketone.
             306          (vi) (A) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in
             307      a U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
             308      (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
             309      (-)-delta-9-(trans)-tetrahydrocannabinol; and
             310          (B) Nabilone, another name for nabilone:
             311      (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
             312      6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
             313          (c) Schedule III:
             314          (i) Unless specifically excepted or unless listed in another schedule, any material,
             315      compound, mixture, or preparation which contains any quantity of the following substances having
             316      a stimulant effect on the central nervous system, including its salts, isomers whether optical,
             317      position, or geometric, and salts of the isomers when the existence of the salts, isomers, and salts
             318      of isomers is possible within the specific chemical designation:
             319          (A) Those compounds, mixtures, or preparations in dosage unit form containing any
             320      stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were listed
             321      on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the Code of
             322      Federal Regulations, and any other drug of the quantitive composition shown in that list for those
             323      drugs or which is the same except that it contains a lesser quantity of controlled substances;
             324          (B) Benzphetamine;
             325          (C) Chlorphentermine;
             326          (D) Clortermine; and
             327          (E) Phendimetrazine.
             328          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             329      compound, mixture, or preparation which contains any quantity of the following substances having
             330      a depressant effect on the central nervous system:
             331          (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
             332      pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients which
             333      are not listed in any schedule;
             334          (B) Any suppository dosage form containing amobarbital, secobarbital, or pentobarbital,
             335      or any salt of any of these drugs which is approved by the Food and Drug Administration for


             336      marketing only as a suppository;
             337          (C) Any substance which contains any quantity of a derivative of barbituric acid or any salt
             338      of any of them;
             339          (D) Chlorhexadol;
             340          (E) Ketamine;
             341          [(E)] (F) Lysergic acid;
             342          [(F)] (G) Lysergic acid amide;
             343          [(G)] (H) Methyprylon;
             344          [(H)] (I) Sulfondiethylmethane;
             345          [(I)] (J) Sulfonethylmethane;
             346          [(J)] (K) Sulfonmethane; and
             347          [(K)] (L) Tiletamine and zolazepam or any of their salts, some trade or other names for
             348      a tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
             349      2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
             350      4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
             351      flupyrazapon.
             352          (iii) Nalorphine.
             353          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             354      compound, mixture, or preparation containing limited quantities of any of the following narcotic
             355      drugs, or their salts calculated as the free anhydrous base or alkaloid:
             356          (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
             357      per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium;
             358          (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams
             359      per dosage unit, with one or more active non-narcotic ingredients in recognized therapeutic
             360      amounts;
             361          (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             362      than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline alkaloid
             363      of opium;
             364          (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
             365      than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             366      recognized therapeutic amounts;


             367          (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
             368      milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
             369      therapeutic amounts;
             370          (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than
             371      15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized
             372      therapeutic amounts;
             373          (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
             374      more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
             375      recognized therapeutic amounts;
             376          (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
             377      one or more active, non-narcotic ingredients in recognized therapeutic amounts.
             378          (v) Unless specifically excepted or unless listed in another schedule, anabolic steroids
             379      including any of the following or any isomer, ester, salt, or derivative of the following that
             380      promotes muscle growth:
             381          (A) Boldenone;
             382          (B) Chlorotestosterone (4-chlortestosterone);
             383          (C) Clostebol;
             384          (D) Dehydrochlormethyltestosterone;
             385          (E) Dihydrotestosterone (4-dihydrotestosterone);
             386          (F) Drostanolone;
             387          (G) Ethylestrenol;
             388          (H) Fluoxymesterone;
             389          (I) Formebulone (formebolone);
             390          (J) Mesterolone;
             391          (K) Methandienone;
             392          (L) Methandranone;
             393          (M) Methandriol;
             394          (N) Methandrostenolone;
             395          (O) Methenolone;
             396          (P) Methyltestosterone;
             397          (Q) Mibolerone;


             398          (R) Nandrolone;
             399          (S) Norethandrolone;
             400          (T) Oxandrolone;
             401          (U) Oxymesterone;
             402          (V) Oxymetholone;
             403          (W) Stanolone;
             404          (X) Stanozolol;
             405          (Y) Testolactone;
             406          (Z) Testosterone; and
             407          (AA) Trenbolone.
             408          Anabolic steroids expressly intended for administration through implants to cattle or other
             409      nonhuman species, and approved by the Secretary of Health and Human Services for use, may not
             410      be classified as a controlled substance.
             411          (d) Schedule IV:
             412          (i) Unless specifically excepted or unless listed in another schedule, any material,
             413      compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not less
             414      than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them;
             415          (ii) Unless specifically excepted or unless listed in another schedule, any material,
             416      compound, mixture, or preparation which contains any quantity of the following substances,
             417      including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and salts
             418      of isomers is possible within the specific chemical designation:
             419          (A) Alprazolam;
             420          (B) Barbital;
             421          (C) Bromazepam;
             422          (D) Butorphanol;
             423          (E) Camazepam;
             424          (F) Chloral betaine;
             425          (G) Chloral hydrate;
             426          (H) Chlordiazepoxide;
             427          (I) Clobazam;
             428          (J) Clonazepam;


             429          (K) Clorazepate;
             430          (L) Clotiazepam;
             431          (M) Cloxazolam;
             432          (N) Delorazepam;
             433          (O) Diazepam;
             434          (P) Estazolam;
             435          (Q) Ethchlorvynol;
             436          (R) Ethinamate;
             437          (S) Ethyl loflazepate;
             438          (T) Fludiazepam;
             439          [(U) Flunitrazepam;]
             440          [(V)] (U) Flurazepam;
             441          [(W)] (V) Halazepam;
             442          [(X)] (W) Haloxazolam;
             443          [(Y)] (X) Ketazolam;
             444          [(Z)] (Y) Loprazolam;
             445          [(AA)] (Z) Lorazepam;
             446          [(BB)] (AA) Lormetazepam;
             447          [(CC)] (BB) Mebutamate;
             448          [(DD)] (CC) Medazepam;
             449          [(EE)] (DD) Meprobamate;
             450          [(FF)] (EE) Methohexital;
             451          [(GG)] (FF) Methylphenobarbital (mephobarbital);
             452          [(HH)] (GG) Midazolam;
             453          [(II)] (HH) Nimetazepam;
             454          [(JJ)] (II) Nitrazepam;
             455          [(KK)] (JJ) Nordiazepam;
             456          [(LL)] (KK) Oxazepam;
             457          [(MM)] (LL) Oxazolam;
             458          [(NN)] (MM) Paraldehyde;
             459          [(OO)] (NN) Pentazocine;


             460          [(PP)] (OO) Petrichloral;
             461          [(QQ)] (PP) Phenobarbital;
             462          [(RR)] (QQ) Pinazepam;
             463          [(SS)] (RR) Prazepam;
             464          [(TT)] (SS) Quazepam;
             465          [(UU)] (TT) Temazepam;
             466          [(VV)] (UU) Tetrazepam;
             467          [(WW)] (VV) Triazolam; and
             468          [(XX)] (WW) Zolpidem.
             469          (iii) Any material, compound, mixture, or preparation of fenfluramine which contains any
             470      quantity of the following substances, including its salts, isomers whether optical, position, or
             471      geometric, and salts of the isomers when the existence of the salts, isomers, and salts of isomers
             472      is possible.
             473          (iv) Unless specifically excepted or unless listed in another schedule, any material,
             474      compound, mixture, or preparation which contains any quantity of the following substances having
             475      a stimulant effect on the central nervous system, including its salts, isomers whether optical,
             476      position, or geometric isomers, and salts of the isomers when the existence of the salts, isomers,
             477      and salts of isomers is possible within the specific chemical designation:
             478          (A) Cathine ((+)-norpseudoephedrine);
             479          (B) Diethylpropion;
             480          (C) Fencamfamine;
             481          (D) Fenproprex;
             482          (E) Mazindol;
             483          (F) Mefenorex;
             484          (G) Pemoline, including organometallic complexes and chelates thereof;
             485          (H) Phentermine;
             486          (I) Pipradrol; and
             487          (J)SPA ((-)-1-dimethylamino-1,2-diphenylethane).
             488          (v) Unless specifically excepted or unless listed in another schedule, any material,
             489      compound, mixture, or preparation which contains any quantity of dextropropoxyphene
             490      (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.


             491          (e) Schedule V: Any compound, mixture, or preparation containing any of the following
             492      limited quantities of narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid,
             493      which includes one or more non-narcotic active medicinal ingredients in sufficient proportion to
             494      confer upon the compound, mixture, or preparation valuable medicinal qualities other than those
             495      possessed by the narcotic drug alone:
             496          (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
             497          (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
             498          (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
             499          (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
             500      atropine sulfate per dosage unit;
             501          (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
             502          (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine
             503      sulfate per dosage unit;
             504          (vii) unless specifically exempted or excluded or unless listed in another schedule, any
             505      material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant effect
             506      on the central nervous system, including its salts, isomers, and salts of isomers; and
             507          (viii) unless specifically excepted or unless listed in another schedule, any material,
             508      compound, mixture, or preparation containing any Buprenorphine and its salts.
             509          Section 2. Section 58-37-5.5 is enacted to read:
             510          58-37-5.5. Recognized controlled substance analogs.
             511          (1) A substance listed under Subsection (2) is an analog, as defined in Section
             512      58-37-2 (1)(f), if the substance, in any quantity, and in any material, compound, mixture, or
             513      preparation, is present in:
             514          (a) any product manufactured, distributed, or possessed for the purpose of human
             515      consumption; or
             516          (b) any product, the use or administration of which results in human consumption.
             517          (2) Substances referred to in Subsection (1) include, but are not limited to:
             518          (a) gamma butyrolactone (GBL);
             519          (b) butyrolactone;
             520          (c) 1,2 butanolide;
             521          (d) 2-oxanolone;


             522          (e) tetrahydro-2-furanone;
             523          (f) dihydro-2 (3H)-furanone;
             524          (g) tetramethylene glycol; and
             525          (h) 1,4 butanediol.
             526          Section 3. Section 58-37c-3 is amended to read:
             527           58-37c-3. Definitions.
             528          In addition to the definitions in Section 58-1-102 , as used in this chapter:
             529          (1) "Board" means the Controlled Substance Precursor Advisory Board created in Section
             530      58-37c-4 .
             531          (2) "Controlled substance precursor" includes a chemical reagent and means any of the
             532      following:
             533          (a) Phenyl-2-propanone;
             534          (b) Methylamine;
             535          (c) Ethylamine;
             536          (d) D-lysergic acid;
             537          (e) Ergotamine and its salts;
             538          (f) Diethyl malonate;
             539          (g) Malonic acid;
             540          (h) Ethyl malonate;
             541          (i) Barbituric acid;
             542          (j) Piperidine and its salts;
             543          (k) N-acetylanthranilic acid and its salts;
             544          (l) Pyrrolidine;
             545          (m) Phenylacetic acid and its salts;
             546          (n) Anthranilic acid and its salts;
             547          (o) Morpholine;
             548          (p) Ephedrine;
             549          (q) Pseudoephedrine;
             550          (r) Norpseudoephedrine;
             551          (s) Phenylpropanolamine;
             552          (t) Benzyl cyanide;


             553          (u) Ergonovine and its salts;
             554          (v) 3,4-Methylenedioxyphenyl-2-propanone;
             555          (w) propionic anhydride;
             556          (x) Insosafrole;
             557          (y) Safrole;
             558          (z) Piperonal;
             559          (aa) N-Methylephedrine;
             560          (bb) N-ethylephedrine;
             561          (cc) N-methylpseudoephedrine;
             562          (dd) N-ethylpseudoephedrine;
             563          (ee) Hydriotic acid;
             564          (ff) gamma butyrolactone(GBL), including butyrolactone, 1,2 butanolide, 2-oxanolone,
             565      tetrahydro-2-furanone, dihydro-2(3H)-furanone, and tetramethylene glycol, but not including
             566      gamma aminobutric acid (GABA);
             567          (gg) 1,4 butanediol;
             568          [(ff)] (hh) any salt, isomer, or salt of an isomer of the chemicals listed in Subsections (a)
             569      through [(ee)] (gg) of this section;
             570          [(gg)] (ii) Crystal iodine;
             571          [(hh)] (jj) any controlled substance precursor listed under the provisions of the Federal
             572      Controlled Substances Act which is designated by the director under the emergency listing
             573      provisions set forth in Section 58-37c-14 ; and
             574          [(ii)] (kk) any chemical which is designated by the director under the emergency listing
             575      provisions set forth in Section 58-37c-14 .
             576          (3) "Deliver," "delivery," "transfer," or "furnish" means the actual, constructive, or
             577      attempted transfer of a controlled substance precursor.
             578          (4) "Matrix" means something, as a substance, in which something else originates,
             579      develops, or is contained.
             580          (5) "Person" means any individual, group of individuals, proprietorship, partnership, joint
             581      venture, corporation, or organization of any type or kind.
             582          (6) "Practitioner" means a physician, dentist, podiatric physician, veterinarian, pharmacist,
             583      scientific investigator, pharmacy, hospital, pharmaceutical manufacturer, or other person licensed,


             584      registered, or otherwise permitted to distribute, dispense, conduct research with respect to,
             585      administer, or use in teaching, or chemical analysis a controlled substance in the course of
             586      professional practice or research in this state.
             587          (7) (a) "Regulated distributor" means a person within the state who provides, sells,
             588      furnishes, transfers, or otherwise supplies a listed controlled substance precursor chemical in a
             589      regulated transaction.
             590          (b) "Regulated distributor" does not include any person excluded from regulation under
             591      this chapter.
             592          (8) (a) "Regulated purchaser" means any person within the state who receives a listed
             593      controlled substance precursor chemical in a regulated transaction.
             594          (b) "Regulated purchaser" does not include any person excluded from regulation under this
             595      chapter.
             596          (9) "Regulated transaction" means any actual, constructive or attempted:
             597          (a) transfer, distribution, delivery, or furnishing by a person within the state to another
             598      person within or outside of the state of a threshold amount of a listed precursor chemical; or
             599          (b) purchase or acquisition by any means by a person within the state from another person
             600      within or outside the state of a threshold amount of a listed precursor chemical.
             601          (10) "Retail distributor" means a grocery store, general merchandise store, drug store, or
             602      other entity or person whose activities as a distributor are limited almost exclusively to sales for
             603      personal use:
             604          (a) in both number of sales and volume of sales; and
             605          (b) either directly to walk-in customers or in face-to-face transactions by direct sales.
             606          (11) "Threshold amount of a listed precursor chemical" means any amount of a controlled
             607      substance precursor; however, the division may exempt from the provisions of this chapter a
             608      specific controlled substance precursor in a specific amount and in certain types of transactions
             609      which provisions for exemption shall be defined by the division by rule adopted pursuant to Title
             610      63, Chapter 46a, Utah Administrative Rulemaking Act.
             611          (12) "Unlawful conduct" as defined in Section 58-1-501 includes knowingly and
             612      intentionally:
             613          (a) engaging in a regulated transaction without first being appropriately licensed or
             614      exempted from licensure under this chapter;


             615          (b) acting as a regulated distributor and selling, transferring, or in any other way conveying
             616      a controlled substance precursor to a person within the state who is not appropriately licensed or
             617      exempted from licensure as a regulated purchaser, or selling, transferring, or otherwise conveying
             618      a controlled substance precursor to a person outside of the state and failing to report the transaction
             619      as required;
             620          (c) acting as a regulated purchaser and purchasing or in any other way obtaining a
             621      controlled substance precursor from a person within the state who is not a licensed regulated
             622      distributor, or purchasing or otherwise obtaining a controlled substance precursor from a person
             623      outside of the state and failing to report the transaction as required;
             624          (d) engaging in a regulated transaction and failing to submit reports and keep required
             625      records of inventories required under the provisions of this chapter or rules adopted pursuant to
             626      this chapter;
             627          (e) making any false statement in any application for license, in any record to be kept, or
             628      on any report submitted as required under this chapter;
             629          (f) with the intent of causing the evasion of the recordkeeping or reporting requirements
             630      of this chapter and rules related to this chapter, receiving or distributing any listed controlled
             631      substance precursor chemical in any manner designed so that the making of records or filing of
             632      reports required under this chapter is not required;
             633          (g) failing to take immediate steps to comply with licensure, reporting, or recordkeeping
             634      requirements of this chapter because of lack of knowledge of those requirements, upon becoming
             635      informed of the requirements;
             636          (h) presenting false or fraudulent identification where or when receiving or purchasing a
             637      listed controlled substance precursor chemical;
             638          (i) creating a chemical mixture for the purpose of evading any licensure, reporting or
             639      recordkeeping requirement of this chapter or rules related to this chapter, or receiving a chemical
             640      mixture created for that purpose;
             641          (j) if the person is at least 18 years of age, employing, hiring, using, persuading, inducing,
             642      enticing, or coercing another person under 18 years of age to violate any provision of this chapter,
             643      or assisting in avoiding detection or apprehension for any violation of this chapter by any federal,
             644      state, or local law enforcement official; and
             645          (k) obtaining or attempting to obtain or to possess any controlled substance precursor or


             646      any combination of controlled substance precursors knowing or having a reasonable cause to
             647      believe that the controlled substance precursor is intended to be used in the unlawful manufacture
             648      of any controlled substance.
             649          (13) "Unprofessional conduct" as defined in Section 58-1-102 and as may be further
             650      defined by rule includes the following:
             651          (a) violation of any provision of this chapter, the Controlled Substance Act of this state
             652      or any other state, or the Federal Controlled Substance Act; and
             653          (b) refusing to allow agents or representatives of the division or authorized law
             654      enforcement personnel to inspect inventories or controlled substance precursors or records or
             655      reports relating to purchases and sales or distribution of controlled substance precursors as such
             656      records and reports are required under this chapter.
             657          Section 4. Section 58-37c-8 is amended to read:
             658           58-37c-8. License -- Exceptions from licensure or regulation.
             659          (1) Any person engaged in a regulated transaction must be appropriately licensed under
             660      this chapter as a regulated distributor and regulated purchaser unless excepted from licensure under
             661      this chapter.
             662          (2) The division shall:
             663          (a) establish the form of application for a license, the requirements for licensure, and fees
             664      for initial licensure and renewal; and
             665          (b) identify required information to be contained in the application as a condition of
             666      licensure.
             667          (3) A practitioner who holds a Utah Controlled Substance License and a Controlled
             668      Substance Registration issued by the Drug Enforcement Administration of the U.S. Government
             669      is excepted from licensure under this chapter.
             670          (4) Any purchase, sale, transfer, furnishing, or receipt of any drug intended for lawful use
             671      in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals,
             672      which contains ephedrine, pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if such
             673      drug is lawfully purchased, sold, transferred, or furnished as an over-the-counter medication
             674      without prescription pursuant to the federal Food, Drug and Cosmetic Act, 21 USC, Sec. 301 et
             675      seq., or regulations adopted thereunder are excepted from licensure, reporting, and recordkeeping
             676      under this chapter.


             677          (5) Any purchase, sale, transfer, receipt, or manufacture of any dietary supplement,
             678      vitamins, minerals, herbs, or other similar substances including concentrates or extracts, which are
             679      not otherwise prohibited by law, which may contain naturally occurring amounts of chemicals or
             680      substances listed in this chapter, or in rules adopted pursuant to Title 63, Chapter 46a, Utah
             681      Administrative Rulemaking Act, are exempt from licensure under this chapter.
             682          (6) A purchaser of two ounces or less of crystal iodine in a single transaction is not
             683      required to be licensed as a regulated purchaser if the transaction complies with Section 58-37c-18 .
             684          (7) Any purchase, sale, transfer, receipt, or manufacture of any product that contains any
             685      precursor chemical listed in Subsection 58-37c-3 (2)(ff) or (gg) and that is not intended for human
             686      consumption is exempt from licensure, regulation, or criminal penalties under this chapter.


[Bill Documents][Bills Directory]